Tracon Pharmaceuticals, Inc.: Nasdaq/NYSE listing notice — TRACON receives Nasdaq deficiency notices for market value <$35M and bid price <$1.00

Tracon Pharmaceuticals, Inc.

On June 8, 2023, TRACON received notices that its market value was below $35M and bid price below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until December 5, 2023, to regain compliance with both Nasdaq listing rules.
To regain compliance, market value must be >= $35M and bid price >= $1.00 for ten consecutive business days during the grace period.
If not compliant by deadline, could face delisting; company may appeal or seek additional 180-day period for bid price via reverse stock split.
TRACON is evaluating potential actions to regain compliance; no assurance of maintaining listing on Nasdaq.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

5550(b)(2) (the “Market Value Rule”), and (ii) for 30 consecutive business days preceding the date of the Notices, the closing bid price of the Company’s common stock was below $1.00 per share, which is the minimum required closing bid price for continued listing on the Nasdaq Capital Market pursuant to Listing Rule 5550(a)(2) (the “Minimum Bid Price

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Tracon Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C), 5810(c)(3)(A)

Exact text from the filing

June 8, 2023, TRACON Pharmaceuticals, Inc. (the “Company”) received letters (the “Notices”) from the Listing Qualifications staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that (i) for 30 consecutive business days preceding the date of the Notices, the market value of the Company’s common stock was less than $35.0 million, which does not meet the requirement for continued listing on the Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “Market Value Rule”), and (ii) for 30 consecutive business days preceding the date of the Notices, t

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-23-027292

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.